The Seattle-based real estate company said the cuts — which represent about 2% of Zillow's overall headcount — were part of the annual review process. ...

2026 is kicking off on a rocky note in the stock markets, and amid rising macroeconomic uncertainties and geopolitical tensions, it's clear that investors are trying to dive into safety. With that in mind, I'm being especially selectiveWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contri ...

I focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ...

I focus on producing objective, data-driven research, mostly about small- to mid-cap companies, as these tend to be overlooked by many investors. From time to time, though, I also look at large-cap names, just to give a fuller sense of the broader equity markets.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ...

Designation further supports (Z)-Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation SEATTLE, Jan. 16, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced that the U.S. Food and Drug Administration ("FDA") Office of Orphan Products Development ("OOPD") ha ...

We came across a bearish thesis on Zillow Group, Inc. on investing subreddit by Guy_PCS. In this article, we will summarize the bears’ thesis on ZG. Zillow Group, Inc.'s share was trading at $67.80 as of January 13th. ZG’s forward P/E was 32.89 according to Yahoo Finance. Studio Grand Ouest/Shutterstock.com Zillow Group, Inc. operates real estate brands in mobile applications and Websites in the United States. ZG faced renewed investor concern after its stock declined more than 5.5% following reports th ...

Zillow (NASDAQ: Z and ZG) is recognized as one of the go-to platforms for homebuyers searching for properties, yet the bulk of its revenue stems from real estate listing agents who pay for leads. Under CEO Jeremy Wacksman, the company is increasingly shifting focus toward the transaction side of the real estate process, viewing it as a more promising avenue for growth. As Wacksman has noted, “It’s a better business to be in,” highlighting the potential for deeper involvement beyond mere lead generation.Cent ...

Core Insights - Atossa Therapeutics has received a "Study May Proceed" letter from the FDA for its clinical study of (Z)-endoxifen in metastatic breast cancer, marking a significant regulatory milestone for the company [1][2] Group 1: Product Development - (Z)-endoxifen is a potent Selective Estrogen Receptor Modulator/Degrader (SERM/D) with demonstrated activity across multiple mechanisms, currently under evaluation for oncology and rare diseases [3] - The proprietary oral formulation of (Z)-endoxifen has shown a favorable safety profile and distinct pharmacology compared to tamoxifen, including ER-targeted effects and PKC inhibition [3] - The (Z)-endoxifen program is supported by a growing global intellectual property portfolio, including multiple recently issued U.S. patents and numerous pending applications worldwide [4] Group 2: Company Overview - Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative medicines in oncology and other areas of significant unmet medical need [5] - The company's lead product candidate, (Z)-endoxifen, is currently in development across several clinical settings [5]

Seasonal cooling is said to be finally seeping into the US real estate / property market after an “unseasonably” active fall, according to the latest market report from Zillow (Nasdaq: Z and ZG). Price cuts from sellers dropped back to normal levels from near-record highs; a rare instance of buyers “losing a bit of leverage in a year when many housing trends moved in their favor.”Zillow Senior Economist Kara Ng said:“Affordability is still a hurdle for home buyers, but 2025 brought real progress. Mortgage p ...

Core Viewpoint - Zillow Group (Z) is currently experiencing a decline in stock price, attributed to Alphabet's Google testing home sales ads in search results, but several banks believe the impact on Zillow will be limited [1][6]. Group 1: Stock Performance - Zillow's stock has decreased by 20% over the past three months and nearly 10% since the news of Google's ad placement emerged on December 12 [4]. - Bernstein maintains a bullish outlook on Zillow, with a price target approximately 50% above the current stock price [1]. Group 2: Financial Performance - In Q3, Zillow's revenue increased to $676 million, up from $581 million in the same period last year [5]. - The company reported a net income of $10 million from continuous operations, a significant improvement from a net loss of $20 million in Q3 of 2024 [5]. Group 3: Market Position and Ratios - Zillow's price-sales ratio stands at 7.6 times, while its price-book ratio is 3.4 times, with a market capitalization of $16.65 billion [4]. Group 4: Industry Impact - RBC Capital suggests that while Zillow may face some challenges from Google's initiative, the impact will not be severe due to potential conflicts with Multiple Listing Service (MLS) distribution rules [6]. - Wells Fargo also predicts minimal financial impact on Zillow, noting that the company derives little traffic from organic search [7].